The development of a CDK2-docking site peptide that inhibits p53 and sensitizes cells to death.

Cell cycle (Georgetown, Tex.)

Volumn 3, Issue 1, 2004, Pages 80-89

  Ferguson, Michelle ^a   Luciani, M Gloria ^a   Finlan, Lee ^a   Rankin, Elaine M ^a   Ibbotson, Sally ^a   Fersht, Alan ^a   Hupp, Tedd R ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

6 O CYCLOHEXYLMETHYLGUANINE; ANTINEOPLASTIC AGENT; CDK2 PROTEIN, HUMAN; CDKN1A PROTEIN, HUMAN; CYCLIN A; CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE INHIBITOR 1A; CYCLINE; DRUG DERIVATIVE; ENZYME INHIBITOR; GUANINE; PEPTIDE FRAGMENT; PROTEIN P53; PURINE DERIVATIVE; ROSCOVITINE;

ARTICLE; BINDING SITE; CELL CULTURE; CELL DEATH; DRUG ANTAGONISM; HUMAN; METABOLISM; MUTATION; PHOSPHORYLATION; PHYSIOLOGY; PROTEIN BINDING;

ANTINEOPLASTIC AGENTS; BINDING SITES; CDC2-CDC28 KINASES; CELL DEATH; CYCLIN A; CYCLIN-DEPENDENT KINASE 2; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLIN-DEPENDENT KINASES; CYCLINS; ENZYME INHIBITORS; GUANINE; HUMANS; MUTATION; PEPTIDE FRAGMENTS; PHOSPHORYLATION; PROTEIN BINDING; PURINES; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53;

EID: 2942673177     PISSN: 15384101     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)